Increased hepatoprotective effects of the novel farnesoid X receptor agonist INT-787 versus obeticholic acid in a mouse model of nonalcoholic steatohepatitis

• Luciano Adorini,

  Roles Conceptualization, Data curation, Funding acquisition, Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Intercept Pharmaceuticals, Inc., San Diego, California, United States of America

  https://orcid.org/0000-0001-8109-339X

  ⨯
• Kristoffer Rigbolt,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Gubra, Hørsholm, Denmark

  ⨯
• Michael Feigh,

  Roles Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Gubra, Hørsholm, Denmark

  ⨯
• Jonathan Roth,

  Roles Conceptualization, Data curation, Funding acquisition, Methodology, Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Intercept Pharmaceuticals, Inc., San Diego, California, United States of America

  ⨯
• Mary Erickson

  Roles Conceptualization, Data curation, Funding acquisition, Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: mary.erickson@interceptpharma.com

  Affiliation Intercept Pharmaceuticals, Inc., San Diego, California, United States of America

  https://orcid.org/0000-0002-6514-6073

  ⨯